Lupin Limited (NSE:LUPIN)
1,976.70
-3.60 (-0.18%)
Nov 16, 2026, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 901.9 billion as of November 16, 2026. Its market cap has decreased by 3.92% in one year.
Market Cap
901.90B
Enterprise Value
888.28B
Revenue
307.46B
Global Rank
n/a
Country Rank
n/a
PE Ratio
17.42
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 901.90B, an increase of 90,257.81%. That is a compound annual growth rate of 28.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 901.90B | -6.52% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.31T |
| Zydus Lifesciences | 1.19T |
| Cipla | 1.12T |
| Mankind Pharma | 1.09T |
| Aurobindo Pharma | 1.05T |
| Glenmark Pharmaceuticals | 745.06B |
| Alkem Laboratories | 611.46B |
| Gland Pharma | 550.99B |